Response to "Comment on 'AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137'" [Med. Phys. 36, 5310-5322 (2009)].
Nath
Ravinder
R
Bice
William S
WS
Butler
Wayne M
WM
Chen
Zhe
Z
Meigooni
Ali S
AS
Narayana
Vrinda
V
Rivard
Mark J
MJ
Yu
Yan
Y
D000465:Algorithms; D001918:Brachytherapy / Q000379:methods*; D002588:Cesium Radioisotopes / Q000494:pharmacology; D006801:Humans; D007457:Iodine Radioisotopes / Q000494:pharmacology; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D010165:Palladium / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011868:Radioisotopes / Q000494:pharmacology; D011874:Radiometry / Q000379:methods; D011879:Radiotherapy Dosage; D013997:Time Factors; D014057:Tomography, X-Ray Computed / Q000379:methods
D002588:Cesium Radioisotopes; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium